2018-06-06
AUTHORSNorbert Gattermann , Christian Rose
ABSTRACTIron overload in MDS results from increased intestinal iron absorption due to ineffective erythropoiesis and, more importantly, from chronic transfusion therapy. Blood transfusions are necesssary to extend the survival of patients with MDS and improve their quality of life. However, the ensuing transfusional iron overload has a dose dependent negative impact on survival. Cardiac dysfunction appears to be relevant in this context, as a consequence of chronic anemia, age-related cardiac comorbidity, and iron overload. In addition, iron-related endothelial dysfunction and a higher risk of infection should be taken into account. Iron overload may also aggravate the bone marrow failure in MDS. Clinical trials have shown that iron chelators can improve hematopoiesis in a minority of transfusion-dependent patients. Analyses of registry data suggest that iron chelation provides a survival benefit for patients with MDS, but data from a randomized clinical trial are still lacking. More... »
PAGES105-118
Myelodysplastic Syndromes
ISBN
978-3-319-76878-6
978-3-319-76879-3
http://scigraph.springernature.com/pub.10.1007/978-3-319-76879-3_8
DOIhttp://dx.doi.org/10.1007/978-3-319-76879-3_8
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1104403575
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Oncology, University Hospital, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.14778.3d",
"name": [
"Department of Hematology, Oncology and Clinical Oncology, University Hospital, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Gattermann",
"givenName": "Norbert",
"id": "sg:person.01273447501.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service d\u2019onco h\u00e9matologie, H\u00f4pital Saint Vincent de Paul, Universit\u00e9 Catholique de Lille, Lille, France",
"id": "http://www.grid.ac/institutes/grid.417666.4",
"name": [
"Service d\u2019onco h\u00e9matologie, H\u00f4pital Saint Vincent de Paul, Universit\u00e9 Catholique de Lille, Lille, France"
],
"type": "Organization"
},
"familyName": "Rose",
"givenName": "Christian",
"id": "sg:person.0726474715.75",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726474715.75"
],
"type": "Person"
}
],
"datePublished": "2018-06-06",
"datePublishedReg": "2018-06-06",
"description": "Iron overload in MDS results from increased intestinal iron absorption due to ineffective erythropoiesis and, more importantly, from chronic transfusion therapy. Blood transfusions are necesssary to extend the survival of patients with MDS and improve their quality of life. However, the ensuing transfusional iron overload has a dose dependent negative impact on survival. Cardiac dysfunction appears to be relevant in this context, as a consequence of chronic anemia, age-related cardiac comorbidity, and iron overload. In addition, iron-related endothelial dysfunction and a higher risk of infection should be taken into account. Iron overload may also aggravate the bone marrow failure in MDS. Clinical trials have shown that iron chelators can improve hematopoiesis in a minority of transfusion-dependent patients. Analyses of registry data suggest that iron chelation provides a survival benefit for patients with MDS, but data from a randomized clinical trial are still lacking.",
"editor": [
{
"familyName": "Platzbecker",
"givenName": "Uwe",
"type": "Person"
},
{
"familyName": "Fenaux",
"givenName": "Pierre",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-3-319-76879-3_8",
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-3-319-76878-6",
"978-3-319-76879-3"
],
"name": "Myelodysplastic Syndromes",
"type": "Book"
},
"keywords": [
"iron overload",
"clinical trials",
"iron chelation",
"chronic transfusion therapy",
"survival of patients",
"transfusional iron overload",
"transfusion-dependent patients",
"randomized clinical trials",
"intestinal iron absorption",
"quality of life",
"bone marrow failure",
"cardiac comorbidities",
"endothelial dysfunction",
"survival benefit",
"blood transfusion",
"cardiac dysfunction",
"chronic anemia",
"transfusion therapy",
"dose-dependent negative impact",
"registry data",
"ineffective erythropoiesis",
"high risk",
"iron absorption",
"marrow failure",
"patients",
"iron chelators",
"dysfunction",
"trials",
"overload",
"survival",
"MDS",
"transfusion",
"comorbidities",
"anemia",
"therapy",
"infection",
"erythropoiesis",
"risk",
"hematopoiesis",
"failure",
"chelation",
"chelators",
"negative impact",
"minority",
"data",
"life",
"benefits",
"addition",
"quality",
"consequences",
"impact",
"MDS results",
"analysis",
"results",
"absorption",
"context",
"account"
],
"name": "Iron Chelation",
"pagination": "105-118",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1104403575"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-3-319-76879-3_8"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-3-319-76879-3_8",
"https://app.dimensions.ai/details/publication/pub.1104403575"
],
"sdDataset": "chapters",
"sdDatePublished": "2022-08-04T17:14",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/chapter/chapter_116.jsonl",
"type": "Chapter",
"url": "https://doi.org/10.1007/978-3-319-76879-3_8"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-76879-3_8'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-76879-3_8'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-76879-3_8'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-76879-3_8'
This table displays all metadata directly associated to this object as RDF triples.
131 TRIPLES
22 PREDICATES
81 URIs
74 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/978-3-319-76879-3_8 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1102 |
3 | ″ | schema:author | N3463595f45ba4543996d3b7caf27f049 |
4 | ″ | schema:datePublished | 2018-06-06 |
5 | ″ | schema:datePublishedReg | 2018-06-06 |
6 | ″ | schema:description | Iron overload in MDS results from increased intestinal iron absorption due to ineffective erythropoiesis and, more importantly, from chronic transfusion therapy. Blood transfusions are necesssary to extend the survival of patients with MDS and improve their quality of life. However, the ensuing transfusional iron overload has a dose dependent negative impact on survival. Cardiac dysfunction appears to be relevant in this context, as a consequence of chronic anemia, age-related cardiac comorbidity, and iron overload. In addition, iron-related endothelial dysfunction and a higher risk of infection should be taken into account. Iron overload may also aggravate the bone marrow failure in MDS. Clinical trials have shown that iron chelators can improve hematopoiesis in a minority of transfusion-dependent patients. Analyses of registry data suggest that iron chelation provides a survival benefit for patients with MDS, but data from a randomized clinical trial are still lacking. |
7 | ″ | schema:editor | Nc3683c72739640daad8db540b7d72138 |
8 | ″ | schema:genre | chapter |
9 | ″ | schema:isAccessibleForFree | false |
10 | ″ | schema:isPartOf | Nc25609b973a34ef5a079bb59dd64a8b1 |
11 | ″ | schema:keywords | MDS |
12 | ″ | ″ | MDS results |
13 | ″ | ″ | absorption |
14 | ″ | ″ | account |
15 | ″ | ″ | addition |
16 | ″ | ″ | analysis |
17 | ″ | ″ | anemia |
18 | ″ | ″ | benefits |
19 | ″ | ″ | blood transfusion |
20 | ″ | ″ | bone marrow failure |
21 | ″ | ″ | cardiac comorbidities |
22 | ″ | ″ | cardiac dysfunction |
23 | ″ | ″ | chelation |
24 | ″ | ″ | chelators |
25 | ″ | ″ | chronic anemia |
26 | ″ | ″ | chronic transfusion therapy |
27 | ″ | ″ | clinical trials |
28 | ″ | ″ | comorbidities |
29 | ″ | ″ | consequences |
30 | ″ | ″ | context |
31 | ″ | ″ | data |
32 | ″ | ″ | dose-dependent negative impact |
33 | ″ | ″ | dysfunction |
34 | ″ | ″ | endothelial dysfunction |
35 | ″ | ″ | erythropoiesis |
36 | ″ | ″ | failure |
37 | ″ | ″ | hematopoiesis |
38 | ″ | ″ | high risk |
39 | ″ | ″ | impact |
40 | ″ | ″ | ineffective erythropoiesis |
41 | ″ | ″ | infection |
42 | ″ | ″ | intestinal iron absorption |
43 | ″ | ″ | iron absorption |
44 | ″ | ″ | iron chelation |
45 | ″ | ″ | iron chelators |
46 | ″ | ″ | iron overload |
47 | ″ | ″ | life |
48 | ″ | ″ | marrow failure |
49 | ″ | ″ | minority |
50 | ″ | ″ | negative impact |
51 | ″ | ″ | overload |
52 | ″ | ″ | patients |
53 | ″ | ″ | quality |
54 | ″ | ″ | quality of life |
55 | ″ | ″ | randomized clinical trials |
56 | ″ | ″ | registry data |
57 | ″ | ″ | results |
58 | ″ | ″ | risk |
59 | ″ | ″ | survival |
60 | ″ | ″ | survival benefit |
61 | ″ | ″ | survival of patients |
62 | ″ | ″ | therapy |
63 | ″ | ″ | transfusion |
64 | ″ | ″ | transfusion therapy |
65 | ″ | ″ | transfusion-dependent patients |
66 | ″ | ″ | transfusional iron overload |
67 | ″ | ″ | trials |
68 | ″ | schema:name | Iron Chelation |
69 | ″ | schema:pagination | 105-118 |
70 | ″ | schema:productId | Nbee07a083eb24fed9d537d15694c25bf |
71 | ″ | ″ | Ne5a9cf61a07f496890948f2c1905b3c3 |
72 | ″ | schema:publisher | Ncda4d867ce144c2e83518c822f514ebb |
73 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1104403575 |
74 | ″ | ″ | https://doi.org/10.1007/978-3-319-76879-3_8 |
75 | ″ | schema:sdDatePublished | 2022-08-04T17:14 |
76 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
77 | ″ | schema:sdPublisher | N18766db0ca034a01a7c9a256639aca7f |
78 | ″ | schema:url | https://doi.org/10.1007/978-3-319-76879-3_8 |
79 | ″ | sgo:license | sg:explorer/license/ |
80 | ″ | sgo:sdDataset | chapters |
81 | ″ | rdf:type | schema:Chapter |
82 | N18766db0ca034a01a7c9a256639aca7f | schema:name | Springer Nature - SN SciGraph project |
83 | ″ | rdf:type | schema:Organization |
84 | N2801b55bcaf74caabf4613732268871f | schema:familyName | Platzbecker |
85 | ″ | schema:givenName | Uwe |
86 | ″ | rdf:type | schema:Person |
87 | N3463595f45ba4543996d3b7caf27f049 | rdf:first | sg:person.01273447501.34 |
88 | ″ | rdf:rest | N5c8c4178e72e4652b1977eda6c24e305 |
89 | N5c8c4178e72e4652b1977eda6c24e305 | rdf:first | sg:person.0726474715.75 |
90 | ″ | rdf:rest | rdf:nil |
91 | Na53e6b9efaf44f2191c6df75e4652b79 | schema:familyName | Fenaux |
92 | ″ | schema:givenName | Pierre |
93 | ″ | rdf:type | schema:Person |
94 | Nbee07a083eb24fed9d537d15694c25bf | schema:name | doi |
95 | ″ | schema:value | 10.1007/978-3-319-76879-3_8 |
96 | ″ | rdf:type | schema:PropertyValue |
97 | Nc1c82dd61dc848399a6088757d94c1a2 | rdf:first | Na53e6b9efaf44f2191c6df75e4652b79 |
98 | ″ | rdf:rest | rdf:nil |
99 | Nc25609b973a34ef5a079bb59dd64a8b1 | schema:isbn | 978-3-319-76878-6 |
100 | ″ | ″ | 978-3-319-76879-3 |
101 | ″ | schema:name | Myelodysplastic Syndromes |
102 | ″ | rdf:type | schema:Book |
103 | Nc3683c72739640daad8db540b7d72138 | rdf:first | N2801b55bcaf74caabf4613732268871f |
104 | ″ | rdf:rest | Nc1c82dd61dc848399a6088757d94c1a2 |
105 | Ncda4d867ce144c2e83518c822f514ebb | schema:name | Springer Nature |
106 | ″ | rdf:type | schema:Organisation |
107 | Ne5a9cf61a07f496890948f2c1905b3c3 | schema:name | dimensions_id |
108 | ″ | schema:value | pub.1104403575 |
109 | ″ | rdf:type | schema:PropertyValue |
110 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
111 | ″ | schema:name | Medical and Health Sciences |
112 | ″ | rdf:type | schema:DefinedTerm |
113 | anzsrc-for:1102 | schema:inDefinedTermSet | anzsrc-for: |
114 | ″ | schema:name | Cardiorespiratory Medicine and Haematology |
115 | ″ | rdf:type | schema:DefinedTerm |
116 | sg:person.01273447501.34 | schema:affiliation | grid-institutes:grid.14778.3d |
117 | ″ | schema:familyName | Gattermann |
118 | ″ | schema:givenName | Norbert |
119 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34 |
120 | ″ | rdf:type | schema:Person |
121 | sg:person.0726474715.75 | schema:affiliation | grid-institutes:grid.417666.4 |
122 | ″ | schema:familyName | Rose |
123 | ″ | schema:givenName | Christian |
124 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726474715.75 |
125 | ″ | rdf:type | schema:Person |
126 | grid-institutes:grid.14778.3d | schema:alternateName | Department of Hematology, Oncology and Clinical Oncology, University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany |
127 | ″ | schema:name | Department of Hematology, Oncology and Clinical Oncology, University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany |
128 | ″ | rdf:type | schema:Organization |
129 | grid-institutes:grid.417666.4 | schema:alternateName | Service d’onco hématologie, Hôpital Saint Vincent de Paul, Université Catholique de Lille, Lille, France |
130 | ″ | schema:name | Service d’onco hématologie, Hôpital Saint Vincent de Paul, Université Catholique de Lille, Lille, France |
131 | ″ | rdf:type | schema:Organization |